Project Grant RF1TW013267
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $234,750 to the University of Notre Dame to conduct research on polymicrobial interactions during catheter-associated urinary tract infections (CAUTI). The key objectives are to: Investigate the antagonistic effects of Escherichia coli (E. coli) against Candida albicans (C. albicans), specifically examining the...
- This $1.23 million Project Grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases will fund research at Loyola University of Chicago from June 2022 to May 2025 under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant aims to further the university's investigation into how certain species of Lactobacillus bacteria found in the female urinary tract can control colonization of uropathogenic Escherichia coli (UPEC) through...
- This $216,478 National Science Foundation project grant through the Integrative Activities program (CFDA 47.083) will fund research at New Mexico State University in collaboration with the United States Environmental Protection Agency to investigate the pathogenicity of bacteria surviving water disinfection processes. The two-year project beginning February 1, 2023 will explore the impact of chlorine water treatment on bacterial pathogens using advanced cellular assays and metatranscriptomics....
- This $809,427 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research on the impact of polymicrobial interactions and within-host adaptation on the pathogenesis of catheter-associated urinary tract infections (CAUTI). The award recipient, The Research Foundation For The State University Of New York (RF SUNY) doing business as Sponsored...
- This federal Project Grant award of $2,750,557.00, awarded on September 11, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID), supports research under the Allergy and Infectious Diseases Research program (CFDA 93.855) to study how vertically transferred antibodies can protect newborn babies from Escherichia coli (E. coli) infection. The research, conducted by Children's Hospital Medical Center, aims to understand why neonatal E. coli infection is relatively rare in humans...
- This $117,000 Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), to the Research Institute at Nationwide Children's Hospital. The project aims to define the mechanisms by which the transcription factor STAT3 contributes to antimicrobial host defense in the human urothelium (bladder lining) against urinary tract infections (UTIs). Key...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $400,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Baylor College of Medicine in Houston, Texas. The funding will support pre-clinical studies to test the prophylactic efficacy of a potential vaccine against extraintestinal pathogenic E. coli (ExPEC), a member of the human microbiome that has become a leading cause of antibiotic-resistant mortality worldwide. The research...
- This Project Grant award, totaling $377,648, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research on the role of Proteus mirabilis RTX proteins in polymicrobial biofilm formation and the pathogenesis of catheter-associated urinary tract infections (CAUTIs). The research aims to examine the expression of P. mirabilis RTX proteins during polymicrobial biofilm...
- The National Science Foundation (NSF) awarded a $949,997 Project Grant to Iowa State University of Science and Technology under the Biological Sciences program (CFDA 47.074) to investigate the role of environmental factors in the development of antimicrobial resistance (AMR) in municipal wastewater treatment plants. The five-year research project, starting November 1, 2023, will conduct field, laboratory, and computational studies to determine how susceptible bacterial strains are replaced by...
- This Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) in the amount of $419,999 supports research on the fate of norovirus, the virus that causes the "stomach flu," in water and wastewater treatment operations. The project will use a newly developed laboratory method to measure infectious norovirus and investigate how it is removed through various water treatment processes, including chlorine and UV disinfection, membrane filtration,...
This $3,400,004 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate the role of waterborne Escherichia coli transmission as a cause of community-acquired urinary tract infections (UTIs). The key objectives are to: (1) model the drivers and dynamics of E. coli contamination in water systems, (2) identify socio-behavioral, epidemiological, genomic, and ecological factors associated with E. coli UTIs and evaluate water as a transmission source, and (3) estimate the impact of modeled waterborne E. coli exposures on UTI risk. This multi-year research project aims to revolutionize the understanding of UTI etiology and the ecology of uropathogenic E. coli, as well as inform interventions to improve water quality and prevent disease.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $400.0k | 9/16/25 | ||
| Not listed | $3.0m | 9/7/25 |